CA
DNLI icon

Crewe Advisors’s Denali Therapeutics DNLI Stock Holding History

Crewe Advisors’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-4
Closed -$119 – 676
2023
Q2 		$119 Buy
+4
New +$119 ﹤0.01% 842